duolingo logo.png
Duolingo Reveals the “Most 2021 Phrase” and Launches Second Global Language Report
December 06, 2021 00:00 ET | Duolingo, Inc.
PITTSBURGH, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Duolingo (NASDAQ: DUOL), the world’s #1 language learning platform, this week revealed the “Most 2021 Phrase” which is “I’m mentally exhausted”....
willis.png
Willis Towers Watson expands aviation insurance broking expertise and solutions with acquisition of Aerosure
December 05, 2021 20:30 ET | Willis Towers Watson Public Limited Company
SYDNEY, Australia, Dec. 05, 2021 (GLOBE NEWSWIRE) -- Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, today announced the acquisition of Aerosure, a...
SUBX Logo.jpg
Singapore blockchain startup raised USD 1.2 million in under 3 minutes.
December 05, 2021 20:00 ET | SUBX FINANCE LAB
Singapore, Dec. 05, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire)  "In a gold rush, sell the shovel" - that is precisely what this Singapore- based blockchain startup is doing to catch the...
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer
December 05, 2021 19:00 ET | HUTCHMED (China) Limited
— Recruitment of 687 patients globally completed in fifteen months, ahead of schedule — — FRESCO-2 primary objective is to confirm overall clinical benefit seen in the China FRESCO...
MSB_logo_notag (001).jpg
Rexlemestrocel-L Shows Greatest Treatment Benefit on Major Adverse Cardiovascular Events in High-Risk Heart Failure Patients With Diabetes and/or Myocardial Ischemia
December 05, 2021 18:47 ET | Mesoblast Limited
Key points: Analysis of pre-specified high-risk groups in the DREAM-HF Phase 3 trial of rexlemestrocel-L in patients with chronic heart failure and low ejection fraction (HFrEF) showed greatest...
junshi-topalliance-logo.png
Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12
December 05, 2021 18:06 ET | Junshi Biosciences
SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and...
Anaqua_Logo_Large_Full_Color.png
アナクアが株式会社アスと戦略的パートナーシップを締結
December 05, 2021 18:00 ET | Anaqua Inc
東京, Dec. 06, 2021 (GLOBE NEWSWIRE) --...
JUST SAVE MAX-01.jpg
Save Max International Announces Commercial Real Estate Division
December 05, 2021 16:58 ET | Save Max
TORONTO, Dec. 05, 2021 (GLOBE NEWSWIRE) -- By thinking "Outside the Box"' SAVE MAX INTERNATIONAL has garnered Seven Billion ($7,000,000,000) Dollars in transaction volume during its 11-year history....
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of Concern, Including Omicron
December 05, 2021 14:28 ET | Sorrento Therapeutics, Inc.
A representative of novel MPro inhibitor series, MPI8, dually inhibits MPro and cathepsin L, a key viral entry enzyme, with high potency and selectivity.Other analogs of the series have been evaluated...
FSIS Recall Release 046-2021 - Listeria
December 05, 2021 14:18 ET | USDA Food Safety and Inspection Service
Washington, D.C., Dec. 05, 2021 (GLOBE NEWSWIRE) --                                                                          Recall Release CLASS I RECALLHEALTH RISK: HIGH Congressional and...